NCT05463068Phase 3Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

Study sponsor: Novavax

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-08-17Actual
Enrollment · participants911Actual
Source updated2026-04-17Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview